Robeco Institutional Asset Management B.V. Collegium Pharmaceutical, Inc Transaction History
Robeco Institutional Asset Management B.V.
- $49.7 Billion
- Q3 2024
A detailed history of Robeco Institutional Asset Management B.V. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 114,965 shares of COLL stock, worth $3.44 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
114,965
Previous 31,417
265.93%
Holding current value
$3.44 Million
Previous $1.01 Million
339.37%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding COLL
# of Institutions
255Shares Held
38.6MCall Options Held
100KPut Options Held
21.1K-
Black Rock Inc. New York, NY5.79MShares$174 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$79 Million1.79% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.59MShares$77.6 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$70.3 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.75MShares$52.3 Million0.04% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.02B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...